Bacterial capsules Flashcards

1
Q

whats the Structure of bacterial capsules?

A

• network of acidic polysaccharide
- anchored to OM by covalently to phospholipids or lipid A
• Each capsule contains one type of polysaccharide- oligosaccharide units joined by glycosidic linkages
• Polysaccharide chains are diverse, differing in constituent sugars, branching, linkages, group substitutions
• Antigenic diversity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how diverse are Ag?

A

– P. aeruginosa, 80 serotypes
– E. coli, ~80 serotypes
– S. pneumoniae, ~90 serotypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what the diversity of the E. coli capsule?

A
  • K antigens ~80 different serotypes
  • Four capsular types with two distinct assembly systems (groups 1 and 4 vs 2 and 3)
  • Assembly systems for groups 2 and 3 are encoded by single chromosomal locus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

whats the genetic structure of the e.coli capsule?

A
  • Regions 1 assembly & translocation 6-8kb
  • region 2 is serotype specific synthesis/polymerisation 6kb
  • region 3 export 3 kb
  • 1+3 conserved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the components of Capsules of E. coli assembly

A
KfiABCD - polymerisation 
KpsCMST – translocation & export
KpsU – polymer growth
KpsD – OM transport
KpsE – membrane fusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

give an Overview of functions of bacterial capsules

A
  1. Prevent Desiccation
  2. Serum resistance
  3. ADHERENCE (+/-)
  4. IMMUNE EVASION
  5. Weak immunogens
  6. Molecular mimicry
  7. Antigenic/Phase Variation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the Functions of bacterial capsules?

A
  • regulate access of molecules and ions
  • retain nutrients for bacterial growth
  • prevent desiccation during transmission from host to host
  • promote adherence to surfaces and other bacteria
  • inhibit adherence e.g. in Streptococcus pneumoniae; proposed that amounts of capsular material vary at different stages of pathogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when is the capsule required?

A
  • not required for normal growth in vitro
  • required for survival in host body
  • isolates from invasive infection are encapsulated, but lose capsule when sub-cultured in laboratory conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how does the capsule preform its Major role in evasion of the host immune system

A
  • weakly immunogenic, poor activators of complement
  • inhibit opsonisation
  • negative charge repels phagocytes (sialic acid)
  • shedding removes bound antibodies and complement components
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the Capsules of E. coli’s antigen diversity

A

• Different components:
– K1: sialic acid
– K20: ribose+KDO
• Different structures:
– some straight chain molecules, others branched
– side group substitutions
• K18 and K22 both ribose + ribitol phosphate
• only difference - in K18 ribose is O-acetylated
• difference due to altered expression of a trans-
acetylase – enzyme inactive or repressed in K22
• serotypes unstable
– pure population can revert to K18/K22 mix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is Molecular mimicry?

A

• E. coli K1 - a-2,8 linked sialic acid identical to capsules of:
– Neisseria meningitides group B (meningitis in adults)
– Pasteurella haemolytica (pasteurellosis in lambs)
• silica acid residues with a a-2,8 linkage found on surfaces of eukaryotic cells - glycoconjugates on the neural cell
adhesion molecule (NCAM)
• immunologically recognised as “self” molecular mimicry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why are K antigens less virulent?

A

slightly different sialic acid not recognised as self - more immunogenic, less virulent:
– K1+ : SA is O-acetylated
– N. meningitidis group C: SA is a-2,9 linked
– K92: SA is a-2,9 and a-2,8 linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

give 3 examples of molecular mimicry

A
  1. E. coli K5: glucuronic acid and N-acetylglucosamine
    mimics an intermediate in heparin biosynthesis
  2. E. coli K4: identical with chondroitin, a constituent
    of extracellular matrix
  3. Streptococcus pyogenes capsule: hyaluronic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is Capsules of E. coli’s role in disease

A
  • small fraction of ~80 K antigens associated with disease

- >90% of E. coli from neonatal meningitis are K1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe neonatal meningitis

A

– affects 1 in 2-4000 infants
– initial infection of blood invasion from GI tract or
nasopharynx but tropism for meninges (in brain)
– pathology inflammation of meninges
– sudden onset, kill within 24h, 40% mortality rate
– survivors may have irreversible neurological damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why is K1 a successful virulence factor?

A
  • K1 sialic acid
  • Required for evasion of host defence, and tropism and invasion of brain endothelium
  • successful as very weak immunogen
17
Q

Capsules of meningococci and H. influenzae role in disease

A
  • High frequency of asymptomatic carriage in upper respiratory tract
  • Meningococci frequently cause septicemia by high levels of bacteria in the blood
  • Invasion of meninges leads to meningitis
  • Incidence of bacterial meningitis in the UK is ~1/100,000 people
  • Death occurs in 5-10% of people with serious sequelae in 20% of survivors
18
Q

name the Disease-causing serogroups of H. influenzae

A

b (H. influenzae, Hib)

• Insertion of capsule of Hib into an acapsulate mutant of strain Rd restored bacteremia in animals

19
Q

how do Capsular Vaccines work?

A

Capsular polysaccharide is conjugated to protein (diptheria toxin) to stimulate a T-cell dependent immune response

20
Q

explain the flu vaccine

A

Haemophilus influenzae serogroup b vaccine introduced into UK in 1992 resulting in major drop in cases of meningitis due to this bacteria

21
Q

what is the MenC vaccine?

A

Neisseria meningitidis serogroup C vaccine introduced in 1999 almost eradicated disease due to this serogroup

22
Q

name 5 Modes of transmission

A
– Fecal-oral route
– Oral route – droplets/sputum - direct
– Fomite (infectious environmental surfaces)
– Sexually transmitted
– Vector borne
23
Q

what are the Requirements/Implications of Transmission

A
  • Frequent release of large numbers of organisms
  • Environmental survival – Desiccation – Spores
  • Bottlenecks– Small populations impose restrictions on genetic variation
24
Q

how does Virulence Correlate with Transmission

A
  • Model using Citrobacter rodentium in mice mimics enterpathogenic E. coli infections of humans
  • Type III secretion system is required for virulence so investigated mutants of this system
  • Mice are coprophagic resulting in efficient fecal- oral transmission
  • Infected mice are co-housed with uninfected mouse and examined for signs of morbidity/mortality
25
Q

Bacterial capsules - Summary

A
  •  Capsules are polymers of acidic subunits attached to outer membrane
  •  Multiple genes present in single genetic locus are responsible for biosynthesis, assembly and export of capsules
  •  Capsules have multiple functions with effects on adherence, immune evasion and transmission
  •  Capsule are a major determinants of virulence in E. coli and for meningitis
  •  Transmission requires resistance to desiccation for fecal and oral pathogens
  •  Virulence enhances transmission